Shareholder Alert: Ademi LLP investigates whether Organon & Co. is obtaining a Fair Price for Public Shareholders

MILWAUKEE, April 27, 2026 /PRNewswire/ -- Ademi LLP is investigating Organon (NYSE: OGN) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction with Sun Pharma. Click here to learn how to join our investigation and obtain additional information or contact us at gademi@ademilaw.com or toll-free: 866-264-3995.